Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,800.00
-60.00 (-0.87%)
At close: Dec 5, 2025

Daehan Nupharm Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
201,590202,187204,223197,957166,586149,293
Upgrade
Other Revenue
-0-0--0-0-0
Upgrade
Revenue
201,590202,187204,223197,957166,586149,293
Upgrade
Revenue Growth (YoY)
-0.12%-1.00%3.16%18.83%11.58%11.33%
Upgrade
Cost of Revenue
108,137106,710111,986109,40384,99475,100
Upgrade
Gross Profit
93,45495,47792,23688,55481,59374,193
Upgrade
Selling, General & Admin
69,90370,58563,23756,79950,77943,640
Upgrade
Research & Development
6,8721,3294,1062,2842,1561,812
Upgrade
Amortization of Goodwill & Intangibles
100.98102.2898.91100.2274.0661.18
Upgrade
Other Operating Expenses
993.341,0274,394744.91680.51658.82
Upgrade
Operating Expenses
80,27876,81273,37760,60555,21050,949
Upgrade
Operating Income
13,17618,66518,85927,94926,38323,244
Upgrade
Interest Expense
-1,792-1,760-1,762-1,254-907.33-1,013
Upgrade
Interest & Investment Income
271.1397.171,084405.63233.54126.53
Upgrade
Earnings From Equity Investments
-614.58-466.76-142.53-26.5--26,074
Upgrade
Currency Exchange Gain (Loss)
-81.5-113.09-193.13-230.6-216.93-66.97
Upgrade
Other Non Operating Income (Expenses)
289.94372.02289.669,275-1,347-7,732
Upgrade
EBT Excluding Unusual Items
11,24917,09418,13636,11924,145-11,515
Upgrade
Gain (Loss) on Sale of Investments
2,4311,2812,547-1,608-564.19-1,156
Upgrade
Gain (Loss) on Sale of Assets
-0.53-0.53-0.539.51-0.36-
Upgrade
Pretax Income
13,68018,37520,68334,52023,580-12,671
Upgrade
Income Tax Expense
2,8022,9078,14110,2037,886-2,551
Upgrade
Net Income
10,87815,46812,54224,31715,694-10,120
Upgrade
Net Income to Common
10,87815,46812,54224,31715,694-10,120
Upgrade
Net Income Growth
14.55%23.33%-48.42%54.95%--
Upgrade
Shares Outstanding (Basic)
-1414141414
Upgrade
Shares Outstanding (Diluted)
-1414141414
Upgrade
EPS (Basic)
-1102.08893.601732.581118.17-721.04
Upgrade
EPS (Diluted)
-1102.08893.601732.581118.17-721.04
Upgrade
EPS Growth
-23.33%-48.42%54.95%--
Upgrade
Free Cash Flow
-43,249-14,0832,83010,8225,9584,082
Upgrade
Free Cash Flow Per Share
--1003.40201.62771.04424.51290.83
Upgrade
Gross Margin
46.36%47.22%45.16%44.73%48.98%49.70%
Upgrade
Operating Margin
6.54%9.23%9.23%14.12%15.84%15.57%
Upgrade
Profit Margin
5.40%7.65%6.14%12.28%9.42%-6.78%
Upgrade
Free Cash Flow Margin
-21.45%-6.97%1.39%5.47%3.58%2.73%
Upgrade
EBITDA
17,39722,76322,34031,17729,71226,271
Upgrade
EBITDA Margin
8.63%11.26%10.94%15.75%17.84%17.60%
Upgrade
D&A For EBITDA
4,2214,0983,4813,2283,3303,027
Upgrade
EBIT
13,17618,66518,85927,94926,38323,244
Upgrade
EBIT Margin
6.54%9.23%9.23%14.12%15.84%15.57%
Upgrade
Effective Tax Rate
20.48%15.82%39.36%29.56%33.45%-
Upgrade
Advertising Expenses
-3,0693,6543,4564,1846,309
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.